STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Clinical trials for STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weekly vs. standard chemo: which works better for ovarian cancer?
Disease control OngoingThis phase III trial tested two different schedules of the chemotherapy drug paclitaxel (weekly vs. every three weeks) combined with carboplatin, with or without the targeted drug bevacizumab, in 692 people with advanced ovarian, peritoneal, or fallopian tube cancer. The goal was…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New chemo combo tested for rare ovarian cancer
Disease control OngoingThis study compares two chemotherapy regimens (carboplatin+paclitaxel vs oxaliplatin+capecitabine), each with or without the targeted drug bevacizumab, as first treatment for mucinous ovarian or fallopian tube cancer. About 50 people with newly diagnosed or recurrent disease took…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Heated chemo during surgery may fight recurrent ovarian cancer
Disease control OngoingThis early-phase trial tests the safety and effectiveness of giving heated chemotherapy directly into the abdomen during surgery for advanced or recurrent ovarian, fallopian tube, uterine, or peritoneal cancer. About 40 participants receive this treatment, with some also getting …
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Immune booster shows promise in ovarian cancer fight
Disease control OngoingThis early-phase study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy (carboplatin and paclitaxel) can help control advanced ovarian, fallopian tube, or primary peritoneal cancer. About 18 women with stage III or IV cancer will receive the combina…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
New drug combo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase study tests a new drug (MLN0128) combined with bevacizumab in 50 adults with recurrent glioblastoma or other advanced solid tumors. The goal is to find the safest dose and understand side effects. This is not a cure, but aims to control tumor growth.
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
New drug combo shows promise for recurrent ovarian cancer
Disease control OngoingThis early-phase trial tests adding an experimental drug (berzosertib) to standard chemotherapy (carboplatin and gemcitabine) for people with ovarian, peritoneal, or fallopian tube cancer that has returned and spread. The main goals are to find the safest dose and check for side …
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 03, 2026 13:13 UTC
-
Can a Pre-Surgery drug reveal ovarian Cancer's DNA secrets?
Knowledge-focused OngoingThis early-phase trial studies how the drug adavosertib affects tumor DNA in 38 patients with advanced ovarian, fallopian tube, or primary peritoneal cancer before they undergo surgery. The goal is to learn how the drug changes cancer cell DNA and proteins, which may help doctors…
Matched conditions: STAGE IV FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC